Direct to consumer advertsing in pharmaceutical markets:
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Munich
CESifo
2005
|
| Schriftenreihe: | CESifo working papers
1493 : Category 9, Industrial organisation |
| Schlagworte: | |
| Beschreibung: | Literaturverz. S. 37 - 40 |
| Beschreibung: | 40 S. |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV022171402 | ||
| 003 | DE-604 | ||
| 005 | 20051028000000.0 | ||
| 007 | t | ||
| 008 | 050822s2005 |||| 00||| eng d | ||
| 035 | |a (OCoLC)181473494 | ||
| 035 | |a (DE-599)BVBBV022171402 | ||
| 040 | |a DE-604 |b ger | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-706 | ||
| 100 | 1 | |a Brekke, Kurt R. |e Verfasser |0 (DE-588)124603238 |4 aut | |
| 245 | 1 | 0 | |a Direct to consumer advertsing in pharmaceutical markets |c Kurt R. Brekke ; Michael Kuhn |
| 264 | 1 | |a Munich |b CESifo |c 2005 | |
| 300 | |a 40 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a CESifo working papers |v 1493 : Category 9, Industrial organisation | |
| 500 | |a Literaturverz. S. 37 - 40 | ||
| 650 | 0 | 7 | |a Oligopol |0 (DE-588)4043484-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Marketing |0 (DE-588)4037589-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Marketing |0 (DE-588)4037589-4 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Oligopol |0 (DE-588)4043484-9 |D s |
| 689 | 2 | |5 DE-604 | |
| 700 | 1 | |a Qûn, Mîkā'ēl |e Verfasser |4 aut | |
| 830 | 0 | |a CESifo working papers |v 1493 : Category 9, Industrial organisation |w (DE-604)BV013978326 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-015386109 | ||
Datensatz im Suchindex
| _version_ | 1804136146350899200 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Brekke, Kurt R. Qûn, Mîkā'ēl |
| author_GND | (DE-588)124603238 |
| author_facet | Brekke, Kurt R. Qûn, Mîkā'ēl |
| author_role | aut aut |
| author_sort | Brekke, Kurt R. |
| author_variant | k r b kr krb m q mq |
| building | Verbundindex |
| bvnumber | BV022171402 |
| ctrlnum | (OCoLC)181473494 (DE-599)BVBBV022171402 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01356nam a2200397zcb4500</leader><controlfield tag="001">BV022171402</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20051028000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">050822s2005 |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)181473494</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV022171402</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-706</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Brekke, Kurt R.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)124603238</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Direct to consumer advertsing in pharmaceutical markets</subfield><subfield code="c">Kurt R. Brekke ; Michael Kuhn</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Munich</subfield><subfield code="b">CESifo</subfield><subfield code="c">2005</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">40 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">CESifo working papers</subfield><subfield code="v">1493 : Category 9, Industrial organisation</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturverz. S. 37 - 40</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Oligopol</subfield><subfield code="0">(DE-588)4043484-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Marketing</subfield><subfield code="0">(DE-588)4037589-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Marketing</subfield><subfield code="0">(DE-588)4037589-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Oligopol</subfield><subfield code="0">(DE-588)4043484-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Qûn, Mîkā'ēl</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">CESifo working papers</subfield><subfield code="v">1493 : Category 9, Industrial organisation</subfield><subfield code="w">(DE-604)BV013978326</subfield><subfield code="9"></subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-015386109</subfield></datafield></record></collection> |
| id | DE-604.BV022171402 |
| illustrated | Not Illustrated |
| index_date | 2024-07-02T16:19:54Z |
| indexdate | 2024-07-09T20:51:46Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-015386109 |
| oclc_num | 181473494 |
| open_access_boolean | |
| owner | DE-706 |
| owner_facet | DE-706 |
| physical | 40 S. |
| publishDate | 2005 |
| publishDateSearch | 2005 |
| publishDateSort | 2005 |
| publisher | CESifo |
| record_format | marc |
| series | CESifo working papers |
| series2 | CESifo working papers |
| spelling | Brekke, Kurt R. Verfasser (DE-588)124603238 aut Direct to consumer advertsing in pharmaceutical markets Kurt R. Brekke ; Michael Kuhn Munich CESifo 2005 40 S. txt rdacontent n rdamedia nc rdacarrier CESifo working papers 1493 : Category 9, Industrial organisation Literaturverz. S. 37 - 40 Oligopol (DE-588)4043484-9 gnd rswk-swf Marketing (DE-588)4037589-4 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Arzneimittel (DE-588)4003115-9 s DE-604 Marketing (DE-588)4037589-4 s Oligopol (DE-588)4043484-9 s Qûn, Mîkā'ēl Verfasser aut CESifo working papers 1493 : Category 9, Industrial organisation (DE-604)BV013978326 |
| spellingShingle | Brekke, Kurt R. Qûn, Mîkā'ēl Direct to consumer advertsing in pharmaceutical markets CESifo working papers Oligopol (DE-588)4043484-9 gnd Marketing (DE-588)4037589-4 gnd Arzneimittel (DE-588)4003115-9 gnd |
| subject_GND | (DE-588)4043484-9 (DE-588)4037589-4 (DE-588)4003115-9 |
| title | Direct to consumer advertsing in pharmaceutical markets |
| title_auth | Direct to consumer advertsing in pharmaceutical markets |
| title_exact_search | Direct to consumer advertsing in pharmaceutical markets |
| title_exact_search_txtP | Direct to consumer advertsing in pharmaceutical markets |
| title_full | Direct to consumer advertsing in pharmaceutical markets Kurt R. Brekke ; Michael Kuhn |
| title_fullStr | Direct to consumer advertsing in pharmaceutical markets Kurt R. Brekke ; Michael Kuhn |
| title_full_unstemmed | Direct to consumer advertsing in pharmaceutical markets Kurt R. Brekke ; Michael Kuhn |
| title_short | Direct to consumer advertsing in pharmaceutical markets |
| title_sort | direct to consumer advertsing in pharmaceutical markets |
| topic | Oligopol (DE-588)4043484-9 gnd Marketing (DE-588)4037589-4 gnd Arzneimittel (DE-588)4003115-9 gnd |
| topic_facet | Oligopol Marketing Arzneimittel |
| volume_link | (DE-604)BV013978326 |
| work_keys_str_mv | AT brekkekurtr directtoconsumeradvertsinginpharmaceuticalmarkets AT qunmikael directtoconsumeradvertsinginpharmaceuticalmarkets |